Table of Contents
ISRN Tropical Medicine
Volume 2013 (2013), Article ID 230273, 7 pages
http://dx.doi.org/10.1155/2013/230273
Research Article

Soluble ST2 Does Not Regulate TNF- and IL-6 Production in Dengue Virus-Infected Human Monocytes

Instituto de Virología, Universidad El Bosque, Carrera 7B Bis No. 132-11, Bloque D, Bogotá 110121, Colombia

Received 25 April 2013; Accepted 28 May 2013

Academic Editors: F. Fouque, A. Talvani, and C. Wrenger

Copyright © 2013 Marisol Pérez-Acosta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. G. Guzman, S. B. Halstead, H. Artsob et al., “Dengue: a continuing global threat,” Nature Reviews, vol. 8, no. 12, pp. S7–S16, 2010. View at Google Scholar · View at Scopus
  2. W.-K. Wang, T.-L. Sung, Y.-C. Tsai, C.-L. Kao, S.-M. Chang, and C.-C. King, “Detection of dengue virus replication in peripheral blood mononuclear cells from dengue virus type 2-infected patients by a reverse transcription-real-time PCR assay,” Journal of Clinical Microbiology, vol. 40, no. 12, pp. 4472–4478, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. Z. Kou, M. Quinn, H. Chen et al., “Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells,” Journal of Medical Virology, vol. 80, no. 1, pp. 134–146, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. F. F. O. Von Sydow, M. A. Santiago, P. C. Neves-Souza et al., “Comparison of dengue infection in human mononuclear leukocytes with mosquito C6/36 and mammalian vero cells using flow cytometry to detect virus antigen,” Memorias do Instituto Oswaldo Cruz, vol. 95, no. 4, pp. 483–489, 2000. View at Google Scholar · View at Scopus
  5. Y.-W. Lin, K.-J. Wang, H.-Y. Lei et al., “Virus replication and cytokine production in dengue virus-infected human B lymphocytes,” Journal of Virology, vol. 76, no. 23, pp. 12242–12249, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. N. A. Mentor and I. Kurane, “Dengue virus infection of human T lymphocytes,” Acta Virologica, vol. 41, no. 3, pp. 175–176, 1997. View at Google Scholar · View at Scopus
  7. J. E. Cardier, E. Mariño, E. Romano et al., “Proinflammatory factors present in sera from patients with acute dengue infection induce activation and apoptosis of human microvascular endothelial cells: possible role of TNF-α in endothelial cell damage in dengue,” Cytokine, vol. 30, no. 6, pp. 359–365, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. Carr, H. Hocking, K. Bunting et al., “Supernatants from dengue virus type-2 infected macrophages induce permeability changes in endothelial cell monolayers,” Journal of Medical Virology, vol. 69, no. 4, pp. 521–528, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Maruo, I. Morita, M. Shirao, and S.-I. Murota, “IL-6 increases endothelial permeability in vitro,” Endocrinology, vol. 131, no. 2, pp. 710–714, 1992. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Becerra, R. V. Warke, N. de Bosch, A. L. Rothman, and I. Bosch, “Elevated levels of soluble ST2 protein in dengue virus infected patients,” Cytokine, vol. 41, no. 2, pp. 114–120, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Houghton-Triviño, D. M. Salgado, J. A. Rodríguez, I. Bosch, and J. E. Castellanos, “Levels of soluble ST2 in serum associated with severity of dengue due to tumour necrosis factor alpha stimulation,” Journal of General Virology, vol. 91, no. 3, pp. 697–706, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Dunne and L. A. J. O'Neill, “The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense,” Science STKE, vol. 2003, article re3, no. 171, 2003. View at Google Scholar · View at Scopus
  13. G. Bergers, A. Reikerstorfer, S. Braselmann, P. Graninger, and M. Busslinger, “Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor,” EMBO Journal, vol. 13, no. 5, pp. 1176–1188, 1994. View at Google Scholar · View at Scopus
  14. H. Iwahana, K. Yanagisawa, A. Ito-Kosaka et al., “Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells,” European Journal of Biochemistry, vol. 264, no. 2, pp. 397–406, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Trajkovic, M. J. Sweet, and D. Xu, “T1/ST2—an IL-1 receptor-like modulator of immune responses,” Cytokine and Growth Factor Reviews, vol. 15, no. 2-3, pp. 87–95, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. B. P. Leung, D. Xu, S. Culshaw, I. B. McInnes, and F. Y. Liew, “A novel therapy of murine collagen-induced arthritis with soluble T1/ST2,” Journal of Immunology, vol. 173, no. 1, pp. 145–150, 2004. View at Google Scholar · View at Scopus
  17. K. Oshikawa, K. Yanagisawa, S.-I. Tominaga, and Y. Sugiyama, “ST2 protein induced by inflammatory stimuli can modulate acute lung inflammation,” Biochemical and Biophysical Research Communications, vol. 299, no. 1, pp. 18–24, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. M. J. Sweet, B. P. Leung, D. Kang et al., “A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of toll-like receptor 4 expression,” Journal of Immunology, vol. 166, no. 11, pp. 6633–6639, 2001. View at Google Scholar · View at Scopus
  19. H. Yin, B.-J. Huang, H. Yang et al., “Pretreatment with soluble ST2 reduces warm hepatic ischemia/reperfusion injury,” Biochemical and Biophysical Research Communications, vol. 351, no. 4, pp. 940–946, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Van't Veer, P. S. Van Den Pangaart, M. A. D. Van Zoelen et al., “Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model,” Journal of Immunology, vol. 179, no. 10, pp. 7110–7120, 2007. View at Google Scholar · View at Scopus
  21. M. Mildner, A. Storka, M. Lichtenauer et al., “Primary sources and immunological prerequisites for sST2 secretion in humans,” Cardiovascular Research, vol. 87, no. 4, pp. 769–777, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. J. F. P. Wagenaar, M. H. Gasema, M. G. A. Goris et al., “Soluble ST2 levels are associated with bleeding in patients with severe leptospirosis,” PLoS Neglected Tropical Diseases, vol. 3, no. 6, article e453, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Warke, Molecular dissection of the cellular response to dengue virus infection [Dissertation], Graduate School of Biomedical Sciences; University of Massachusetts, 2008.
  24. Y.-T. Tsai, S.-Y. Chang, C.-N. Lee, and C.-L. Kao, “Human TLR3 recognizes dengue virus and modulates viral replication in vitro,” Cellular Microbiology, vol. 11, no. 4, pp. 604–615, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. E. K. Brint, D. Xu, H. Liu et al., “ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance,” Nature Immunology, vol. 5, no. 4, pp. 373–379, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Takezako, M. Hayakawa, H. Hayakawa et al., “ST2 suppresses IL-6 production via the inhibition of IκB degradation induced by the LPS signal in THP-1 cells,” Biochemical and Biophysical Research Communications, vol. 341, no. 2, pp. 425–432, 2006. View at Publisher · View at Google Scholar · View at Scopus